Lonazolac
Lonazolac is a nonsteroidal anti-inflammatory drug (NSAID).
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
IUPAC name
| |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.428  |
| Chemical and physical data | |
| Formula | C17H13ClN2O2 |
| Molar mass | 312.75032 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
  | |
References
| Pyrazolones / Pyrazolidines | |
|---|---|
| Salicylates | |
| Acetic acid derivatives and related substances | |
| Oxicams | |
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) | |
| Coxibs | |
| Other |
|
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. | |
Prostanoid signaling modulators | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receptor (ligands) |
| ||||||||||||||||||||||||||
| Enzyme (inhibitors) | |||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.